Essential Skills for the Transport Manager Training Course: Understanding and Managing Human Error (ONLINE EVENT)
April 24, 2024 07:13 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Understanding and Managing Human Error - Essential Skills for the Transport Manager Training Course" training has been added to ...
Form 8.3 - UK Commercial Property REIT
April 24, 2024 07:13 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Vanadium Compounds in Emerging Electronics, Electrics, Cooling: Global Market Analysis and Technology Research Report 2024-2044
April 24, 2024 07:12 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Vanadium Compounds in Emerging Electronics, Electrics, Cooling: Markets, Technologies 2024-2044" report has been added to ResearchAndMarkets.com's...
Boussard & Gavaudan Investment Management LLP: Form 8.3 - Network International Holdings PLC
April 24, 2024 07:11 ET
|
Boussard & Gavaudan Investment Management LLP
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Keiretsu Forum Sponsors Quix Labs at the Innovation Funders Showcase During Angel Capital Association's Annual Summit
April 24, 2024 07:08 ET
|
Keiretsu Forum Mid-Atlantic
Keiretsu Forum Mid-Atlantic, South-East, and Texas regions proudly announce their sponsorship of Quix Labs at the upcoming Innovation Funders Showcase.
Europe In-Vitro Diagnostics (IVD) Markets, 2023-2024 & 2029 with Abbott, bioMerieux, Danaher, Hoffmann-La Roche, Bio-Rad, Siemens Healthineers, Thermo Fisher Scientific, and Diasorin Dominating
April 24, 2024 07:06 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Europe In-Vitro Diagnostics (IVD) Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.Europe's in-vitro...
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
April 24, 2024 07:05 ET
|
Travere Therapeutics, Inc.
Travere and CSL Vifor announce EC approval of FILSPARI (sparsentan) for treatment of IgAN, 1st non-immunosuppressive treatment for IgAN approved in Europe
Aðalfundur Klappa Grænna Lausna hf. 14. maí 2024 - leiðréttar ályktunartillögur stjórnar
April 24, 2024 07:02 ET
|
Klappir Grænar Lausnir hf.
Aðalfundur Klappa Grænna Lausna hf. 14. maí 2024 Meðfylgjandi eru leiðréttar ályktunartillögur stjórnar. Leiðréttingin er vegna 4. dagskrárliðar og varðar ákvörðun um meðferð hagnaðar félagsins....
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
April 24, 2024 07:01 ET
|
HOOKIPA Pharma Inc.
NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary...
Rogers Communications Reports First Quarter 2024 Results
April 24, 2024 07:00 ET
|
Rogers Communications, Inc.
Reports nine straight quarters of industry-leading growthReaffirms industry-leading 2024 financial guidance More Canadians continue to choose Rogers over any other carrier 124,000...